MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.290 +0.010 (+0.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
26 27 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 ↗
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
News headline image
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Notice: Update in Lawsuit ↗
San Diego, CA -- (SBWIRE) -- 02/02/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp.... 
Via SBWire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million.... 
Via Benzinga
News headline image
Clover Health Stock Remains a High-Risk High-Reward Play ↗
Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now. 
Via InvestorPlace
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading. 
Via Benzinga
News headline image
7 Worst SPACs for Smart Investors to Skip in 2022 ↗
SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves. 
Via InvestorPlace
News headline image
At Below $3 Clover Health Stock May Be Worth It as a Moonshot ↗
It's unclear whether fortunes will turn around for CLOV stock this year, but among meme plays it may have the most comeback potential. 
Via InvestorPlace
News headline image
Membership Growth Is Making Clover Health a More Convincing Investment ↗
You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment. 
Via InvestorPlace
News headline image
Why Chamath Palihapitiya Is Facing Backlash For His Comments On Uyghur Genocide ↗
Billionaire venture capitalist Chamath Palihapitiya is under fire for comments he made on a podcast dismissing human rights abuses against the Uyghurs in China. What Happened:... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo... 
Via Benzinga
News headline image
Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision ↗
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players. 
Via InvestorPlace
News headline image
Camber Energy, Clover Health, Globalstar Stocks Continue Lower In Key Trend: Will The Bloodbath End? ↗
Camber Energy, Inc (NYSE: CEI), Clover Health Investments Corp (NASDAQ: CLOV) and Globalstar, Inc (NYSE: GSAT) are all trading higher in strong downtrends. A downtrend occurs when... 
Via Benzinga
News headline image
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet ↗
Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud. 
Via InvestorPlace
News headline image
Polestar Looks Like the Right EV Stock At the Wrong Time ↗
Polestar has a lot of what I look for in a growth stock. But with valuations likely to correct further, there's no hurry to jump in now. 
Via InvestorPlace
News headline image
RCL Stock Pressured by Hindenburg Short: 7 Things to Know ↗
RCL stock is in the red since 2022 kicked off. Now, Hindenburg Research is taking full advantage of the cruise company's weaknesses. 
Via InvestorPlace
News headline image
How Did the Meme Stocks Do Last Year? Here’s How ↗
Quick, which ones were over 500% up? And which six were more than 45% down? 
Via Talk Markets
News headline image
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low ↗
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade. 
Via InvestorPlace
News headline image
DeskTop Metal Shares Are Still Off Limits to Buyers ↗
Off and on the price chart, there's work to be done in DM stock before bullish investors consider taking a long position. 
Via InvestorPlace
News headline image
The Two Faces of Clover Health ↗
The Clover Assistant may be great software, but the company behind it is questionable. CLOV Stock is best to be avoided for now. 
Via InvestorPlace
News headline image
2021: The Year in Charts ↗
A look at the charts and themes that tell the story of 2021. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
News headline image
The Steep Drop In Clover Health Stock Sets up an Entry Opportunity ↗
Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here. 
Via InvestorPlace
News headline image
Clover Health Is Not the $2 Billion Stock to Buy for 2022 ↗
Clover Health's market cap dropped 74% in 2021. As we head into 2022, CLOV stock is not the $2 billion market cap you want to buy. 
Via InvestorPlace
News headline image
7 of The Best SPAC Stocks to Put on Your 2022 Watchlist ↗
SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending. 
Via InvestorPlace
News headline image
3 Sleeper Stocks to Buy Now Before 2022 Rolls In ↗
2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year. 
Via InvestorPlace
News headline image
7 Meme Stocks to Sell Before They Lose Momentum ↗
Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear. 
Via InvestorPlace
News headline image
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022 ↗
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022. 
Via InvestorPlace
News headline image
Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope ↗
CLOV stock has underperformed in 2021, became a meme stock, and now has many risks and challenges to face to reach profitability. 
Via InvestorPlace
News headline image
This Buzzed-About Meme Stock Is a No-Brainer Buy at $10 ↗
Chamath Palihapitiya visited Greenville, South Carolina recently, which triggered rumors that one of his SPACs was buying a gaming giant. 
Via InvestorPlace
News headline image
This ETF Brings Exposure To Meme Stocks: A Look At The Holdings ↗
A new exchange traded fund offers investors the chance to own a basket of companies that are considered “meme stocks.” Here’s the details and holdings on the new... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story